SARS‐CoV‐2 NSP7 inhibits type I and III IFN production by targeting the RIG‐I/MDA5, TRIF, and STING signaling pathwaysJian Deng, Pei‐Hui Wang, Shengnan Zheng et al.|Journal of Medical Virology|2023Cited by 37
SARS‐CoV‐2 NSP8 suppresses type I and III IFN responses by modulating the RIG‐I/MDA5, TRIF, and STING signaling pathwaysJian Deng, Pei‐Hui Wang, Shengnan Zheng et al.|Journal of Medical Virology|2023Cited by 24